1.63
Finanzdaten der Biorestorative Therapies Inc-Aktie (BRTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
1,113%
0.3033
|
0.025 | 0.0433 | 0.2336 | 0.0891 |
Cost Of Revenue |
200.07%
0.00873
|
0.00291 | 0.00334 | 0.0182 | 0.00649 |
Gross Profit |
1,233%
0.2946
|
0.0221 | 0.04 | 0.2154 | 0.0826 |
|
25.46%
3.5999
|
4.8296 | 2.7301 | 2.5024 | 2.5514 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
25.33%
3.6086
|
4.8325 | 2.7334 | 2.5206 | 2.5579 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Depreciation and Amortization |
1.87%
0.0527
|
0.0518 | 0.0504 | 0.0483 | 0.0477 |
Operating Income/Loss |
31.25%
-3.3053
|
-4.8075 | -2.6901 | -2.287 | -2.4688 |
Net Interest Income/Expense |
26.06%
0.0739
|
0.10 | 0.119 | 0.1585 | 0.1759 |
|
221.94%
0.649
|
-0.5323 | 1.054 | 1.1956 | -1.5598 |
Income/Loss From Continuing Operations Before Tax |
105.68%
0.3033
|
-5.3398 | 0.0433 | 0.2336 | -4.0286 |
Income/Loss From Continuing Operations After Tax |
50.26%
-2.6563
|
-5.3398 | -1.6361 | -1.0914 | -4.0286 |
|
50.26%
-2.6563
|
-5.3398 | -1.6361 | -1.0914 | -4.0286 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4.59%
8.7404
|
8.3571 | 0.1205 | 8.1215 | 8.1215 |
Diluted Average Shares |
4.59%
8.7404
|
8.3571 | 0.1205 | 8.1215 | 8.1215 |
Basic Earnings Per Share |
53.12%
-0.30
|
-0.64 | -0.20 | -0.13 | -0.50 |
Diluted Earnings Per Share |
53.12%
-0.30
|
-0.64 | -0.20 | -0.13 | -0.50 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):